all stories

A promising new medicine against heart disease fails unexpectedly

Fading2 outlets reported this in 5 reports over 2 days - a further 2 reports reprinted copy already published elsewhere
original reportingcopies
Sat, 7 November 2026peak 4 reports on Sat, 7 November 2026Sun, 8 November 2026

What it is about

DoctorsCardiologistsNPRThe New York TimesCNNNovartisAmgenLillyFierce BiotechNBC NewsHarlan KrumholzLos AngelesSteven NissenEli LillyRoger BlumenthalDavid MaronKarol WatsonAmerican Society For Preventive CardiologyUniversity Of CaliforniaJohns Hopkins University

Who published it, and when

original reportcopyfirst to report
Google News - Top Stories1 original report1 original report
wvxu.org1 copy echoing NPR News
publicradiotulsa.org1 copy echoing NPR News
7 Nov, 14:50over 23 hours8 Nov, 14:14

1 report left out of the cascade - too little in common with the story to place

How it spread - 3 original reports, 2 reprints

  1. Sat, 7 November 2026

    2 reports
    • NPR News14:50

      Doctors expected an experimental drug that lowers a common risk factor for heart attacks would save patients' lives. The medicine made no difference.

      2 reprints
    • Google News - Top Stories14:50first to report

      A promising new medicine against heart disease fails unexpectedly NPR How Cardiologists’ High Hopes for Two Drugs Were Dashed The New York Times Pelacarsen, a promising drug for an inherited heart risk, flops, stunning doctors CNN Novartis’ Lp(a) drug shows zero benefit, casting shadow over Amgen and Lilly programs Fierce Biotech The ‘slam dunk’ that wasn’t: Promising cholesterol drug fails to prevent heart attacks or stroke NBC News

  2. Sun, 8 November 2026

    1 report
    • Google News - Top Stories14:14

      Doctors Absorb the Stunning Failure of Two High-Profile Heart Drugs The New York Times A promising new medicine against heart disease fails unexpectedly NPR The ‘slam dunk’ that wasn’t: Promising cholesterol drug fails to prevent heart attacks or stroke NBC News Trial failures of Novartis, Novo Nordisk heart drugs leave experts guessing Reuters Why the latest heart drug failures should make us all more skeptical of AI hype STAT

One email a week

The stories everytrace watched stay alive - how many independent outlets carried each one, and how long it lasted. No daily digest, no breaking-news alerts.